Press Releases

Browse through our media coverage and official press releases.

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2008
2007
2006
2005
2004
2003
2002

Mar 24: MTBVAC, the first vaccine against Tuberculosis derived from a human source, begins clinical trials in adults in India

Apr 02: Bharat Biotech and Bilthoven Biologicals B.V. Announce Collaboration to Produce and Supply Oral Polio Vaccines

Apr 26: The Vice-President of India Visits Bharat Biotech, Emphasises the Importance of Research and Development

May 24: Dr. Krishna Ella Awarded the Johns Hopkins Bloomberg School Highest Medal of Honour for Exceptional Work in Public Health

Aug 27: Bharat Biotech Launches Next Generation Oral Cholera Vaccine HILLCHOL^®; Expands Manufacturing to Address Global Shortage

Sept 11: Bharat Biotech Announces Collaboration with Alopexx for the Development and Commercialization of Broad-Spectrum Anti-Microbial Vaccine AV0328

Sept 28: Bharat Biotech Collaborates with CII to Restore Historic Stepwells in Telangana
Jan 26: Bharat Biotech launches iNCOVACC^®: World^'s 1^st intranasal COVID vaccine for Primary series and Heterologous booster

Jan 09: COVAXIN^® successfully completes clinical trials in Phase 2/3 in the US
Dec 27: iNCOVACC^® is now available on CoWin, priced at INR 800+GST for Private Markets and INR 325+GST for Governments

Nov 28: iNCOVACC^®,World's first Intranasal Vaccine to receive both Primary series and Heterologous booster approval

Sep 06: Bharat Biotech^'s iNCOVACC^® world^'s first Intra Nasal vaccine receives approval for emergency use in India

Aug 24: Nigeria introduces Bharat Biotech^'s ROTAVAC^® vaccine for immunization in children

Aug 15: Bharat Biotech completes clinical development for phase III trials and booster doses for BBV154 intranasal covid vaccine

Jul 26: Developing a Variant-Proof SARS-CoV-2 Vaccine: a CEPI-funded ExcellGene Partnership with Bharat Biotech and the University of Sydney

Jul 20: COVAXIN^® demonstrates Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants

Jun 17: COVAXIN^® demonstrates robust safety and immunogenicity in children 2-18 years

May 10: CEPI partners with consortium of Bharat Biotech, University of Sydney and ExcellGene to develop ^'variant-proof^' COVID-19 vaccine

Apr 26: COVAXIN^® for Children: India approves COVAXIN^® in Children 6-12 years

Mar 16: Bharat Biotech and Biofabri partner to develop, manufacture and distribute a novel TB vaccine, MTBVAC

Jan 12: COVAXIN^® (BBV152) Booster Shown to Neutralize Both Omicron and Delta Variants of SARS-CoV-2

Jan 08: COVAXIN^® (BBV152) booster dose study shows promising results
Dec 30: COVAXIN^® for Children: Study demonstrates robust safety and immunogenicity in 2-18 Volunteers

Nov 12: Bharat Biotech^'s COVAXIN^® Phase III data published in The Lancet

Nov 03: Bharat Biotech^'s COVAXIN^® Authorized for Emergency Use by the World Health Organization

Jul 03: Bharat Biotech Concludes Final Analysis for COVAXIN^® Efficacy from Phase 3 Clinical Trials

Jun 30: Announcement on Procurement Process

Jun 15: Bharat Biotech Announcement on COVAXIN^® Pricing, Procurement

Jun 03: Ocugen Expands COVAXIN^® Commercialization Rights to Include Canada

May 28: From Vaccine to Vaccination

Apr 21: Bharat Biotech and ICMR Announce Interim Results from Phase 3 trials of COVAXIN^®; Demonstrates overall Interim Clinical Efficacy of 78% and 100% efficacy against Severe COVID-19 disease

Apr 20: Bharat Biotech Announces COVAXIN^® Capacity Expansion to Support vaccination campaigns in India and Worldwide.

Mar 03 : Bharat Biotech Announces Phase 3 Results of COVAXIN^®: India's First COVID-19 Vaccine Demonstrates Interim Clinical Efficacy of 81%

Feb 24 : Ukraine Health Minister Dr. Maksym Stepanov visits Bharat Biotech Vaccine Plant at Hyderabad

Feb 02 : Ocugen and Bharat Bitoech Announce Execution of Definitive Agreement for the Commercialization of COVAXIN^TM in the US Market

Jan 27 : GSK, PATH, and Bharat Biotech sign product transfer agreement to help ensure long-term supply of RTS,S/AS01E malaria vaccine

Jan 12 : Bharat Biotech Signs Agreement with Precisa Medicamentos For Supply of ^'COVAXIN^TM^' to Brazil

Jan 09 : COVAXIN^TM Clinical Trials FAQ^'s

Jan 09 : COVAXIN^TM Bhopal Statement

Jan 03 : Bharat Biotech^'s COVAXIN^TM Emergency Use Authorization Approval by DCGI-CDSCO, MoH&FW

Jan 02 : COVAXIN^TM Clinical Trials Cross 23,000 Subjects, and Forges Ahead, India^'s Largest Phase III Trials
Jan 03 : Bharat Biotech^'s COVAXIN^TM Emergency Use Authorization approval by DCGI-CDSCO, MoH&FW

Jan 02 : COVAXIN^TM Clinical Trials Cross 23,000 Subjects,and Forges Ahead, India^'s Largest Phase III Trials

Dec 22 : Ocugen and Bharat Biotech to Co-Develop COVAXIN^TM For the US Market

Dec 22 : COVAXIN^TM Phase III Clinical Trials Cross 13,000 Subjects, the Half Way Mark and Forges Ahead

Nov 16 : Bharat Biotech starts Phase III trials for COVAXIN^TM

Oct 05: COVAXIN^TM to boost the immune response and longer-lasting immunity with ViroVax^'s adjuvant

Sep 23: Bharat Biotech Inks Licensing Deal with Washington University School of Medicine in St. Louis to advance COVID-19 Intranasal Vaccine

June 29: India^'s 1st COVID-19 Vaccine - COVAXIN^TM, Developed by Bharat Biotech gets DCGI approval for Phase I & II Human Clinical Trials

June 03: CEPI grants US$14.1million to consortium of Bharat Biotech and IVI to advance development of Chikungunya vaccine in collaboration with Ind-CEPI

May 20: Bharat Biotech, Thomas Jefferson University pursue a promising vaccine candidate against COVID-19

May 08: Bharat Biotech leads a CSIR-NMITLI supported project to develop human antibodies for COVID-19

April 02: UW-Madison, FluGen, Bharat Biotech to develop CoroFlu, a coronavirus vaccine
Feb 15: Bharat Biotech Acquires Chiron Behring Vaccines

Nov 14: Chiron Behring Re-Launches It's Rabies Vaccine As "Chirorab^®"

Dec 03: Bharat Biotech Launches ROTAVAC 5D^®- Lowest dose volume rotavirus vaccine in the world
May 11: Bharat Biotech receives National Technology Award for ROTAVAC^®

January 24: WHO Grants Prequalification to Bharat Biotech's rotavirus vaccine, ROTAVAC^®.

January 3: Typbar TCV^®. from Bharat Biotech, World's First Typhoid Conjugate Vaccine Prequalified by WHO
Bharat Biotech Unveils ZIKAVAC First Vaccine Candidate for Zika Virus - Feb 03, 2016
Prime Minister of India launches Made in India ROTAVAC^®. Vaccine for the world - Mar 09, 2015
Bharat Biotech donates REGEN-D^®. to victims of A.P. gas explosion - Jul 01, 2014
Business Leaders Call on Companies to Increase Participation in Improving Health in India - MDG - Nov 13, 2013

Bharat Biotech launches JENVAC^TM - a Novel fully Indigenous Inactivated Japanese Encephalitis vaccine - Oct 04, 2013

Bharat Biotech Launches Typbar-TCV^TM, world's first clinically proven typhoid conjugate vaccine for infants 6 months & older and Adults - Aug 26, 2013

Rotavirus Vaccine Developed in India Demonstrates Strong Efficacy (ENGLISH) - May 14, 2013

Rotavirus Vaccine Developed in India Demonstrates Strong Efficacy (HINDI) - May 14, 2013

Rotavirus Vaccine Developed in India Demonstrates Strong Efficacy (TAMIL) - May 14, 2013

Rotavirus Vaccine Developed in India Demonstrates Strong Efficacy (BENGALI) - May 14, 2013

Rotavirus Vaccine Developed in India Demonstrates Strong Efficacy (TELUGU) - May 14, 2013

Rotavirus Vaccine Developed in India Demonstrates Strong Efficacy (KANNADA) - May 14, 2013

Rotavirus Vaccine Developed in India Demonstrates Strong Efficacy (MALAYALAM) - May 14, 2013

Rotavirus Vaccine Developed in India Demonstrates Strong Efficacy (GUJARATI) - May 14, 2013

Rotavirus Vaccine Developed in India Demonstrates Strong Efficacy (MARATHI) - May 14, 2013
Bharat Biotech and University of Maryland Accelerate Development of New Life Saving Conjugate Vaccine - Jun 18, 2012
Modern Pharmaceuticals- Bharat Biotech: Ushering in a world of possibilities. - Sep 20, 2011

Dr. Krishna Ella's ET Interactive: India must support R&D for Neglected Diseases - Jul 25, 2011

Bharat Biotech announes the price of ROTAVAC

IPM sans anti-rabbies vaccine - May 21, 2011

Another man dies of rabies in Andhra News - May 21, 2011

Man dies of rabies, wife bitten by him hospitalised - May 19, 2011

Thrombolytic Agent for Treatment of Myocardial Infarction Being developed for Emerging Markets by Bharat Biotech - Feb 04, 2011
Bharat Biotech Announces Launch of 'HNVAC'- India's First Cell-culture H1N1 Swine Flu Vaccine

Bharat Biotech Begins Phase I Clinical Trials of HN-VAC - Jan 19, 2010
Bharat Biotech Announces Successful Completion of itsPhase l/ll Clinical Trial for116E Rotavirus Vaccine - May 28, 2008

Bharat Biotech Announces the visit of the Honourable Secretary of the United States Department ofHealth and Human Services, Micheal O.Leavitt to its facilities at Genome Valley,Hyderabad - Jan 08, 2008
Bharat Biotech once again becomes the first Indian vaccine manufacturer to successfully produce Revac-Bmcf, a thimerosal-free Hepatitis B Vaccine - Oct 30, 2007

Bharat Biotech Announces the Launch of BioHib, Indiab's First Haemophilus Influenza type b Vaccine Developed with Indigenous Technology - Sep 03, 2007
ThromboGenics Announces Licence Agreement with Bharat Biotech for Novel Thrombolytic Agent - Dec 05, 2006

NOVAVAX and Bharat Biotech announce a Pandemic Influenza Vaccine Development Alliance - Mar 06, 2006

Bharat Biotech & Partners develop an Indigenous Rotavirus Vaccine - Feb 13, 2006
Acambis joins forces with Bharat Biotech to address unmet need for JE Vaccine in India - Nov 09, 2005

National Institute of Science Technology and Development Studies in New Delhi - Aug 31, 2005

Materials exchange deal meager boost to India's Biotech - Aug 31, 2005

Bharat Biotech launches REGEN-D - Jul 15, 2005

KFDA approves Bharat Biotech Manufacturing Facility - Jan 24, 2005
Tsunami Donation - Dec 31, 2004

Bharat Biotech wins AIMO's Best R&D Award for HIMAX Technology- Sep 15, 2004
BBIL - The First Indian Company to be Awarded Commercial Licence to Manufacture Streptokinase - Aug 09, 2003

A Single Shot Vaccine for Typhoid from Bharat Biotech - May 09, 2003

Bharat Biotech Felicitates Dr. John B. Robbins - Mar 21, 2003
Bharat Biotech Wins Global Patent for Infection Drug - Oct 23, 2002

Strategic Alliance between Bharat Biotech and Unichem Labs - Jun 18, 2002

+ -

Bharat Biotech is a pioneering biotechnology company known for its world-class R&D and manufacturing capabilities. Our mission is to deliver affordable, safe and high-quality vaccines and bio-therapeutics that help people prevail over diseases. We seek to lead innovation in biotechnology in order to lead the fight against disease with a focus on emerging markets.

Quick Links

Our Products

© 2022 Bharat Biotech. All Rights Reserved.